These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2867948)

  • 1. The enzymatic systems involved in the mammalian metabolism of methylamine.
    Dar MS; Morselli PL; Bowman ER
    Gen Pharmacol; 1985; 16(6):557-60. PubMed ID: 2867948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase inhibitors and histamine metabolism.
    Benedetti MS; Ancher JF; Sontag N
    Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
    Feldman JM; Chapman B
    Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors.
    Ulus IH; Maher TJ; Wurtman RJ
    Biochem Pharmacol; 2000 Jun; 59(12):1611-21. PubMed ID: 10799660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting].
    Förster W; Gräbner S
    Acta Biol Med Ger; 1966; 16(6):650-7. PubMed ID: 4383660
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
    Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A
    Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
    Collins GG; Youdim MB; Sandler M
    Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dexamethasone on monoamine oxidase inhibiton by iproniazid in rat brain.
    Veals JW; Korduba CA; Symchowicz S
    Eur J Pharmacol; 1977 Feb; 41(3):291-9. PubMed ID: 837973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK; Molloy BB
    Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.
    Rogers KJ; Thornton JA
    Br J Pharmacol; 1969 Jul; 36(3):470-80. PubMed ID: 5789805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of D-cycloserine with the action of some monoamine oxidase inhibitors.
    Vítek V; Rysánek K
    Biochem Pharmacol; 1965 Oct; 14(10):1417-24. PubMed ID: 4379549
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual action of antidepressant drugs (MAO inhibitors) on insulin release.
    Aleyassine H; Gardiner RJ
    Endocrinology; 1975 Mar; 96(3):702-10. PubMed ID: 1090438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC; Schwartz A
    Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147
    [No Abstract]   [Full Text] [Related]  

  • 17. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW; Wong CJ; Hemrick-Luecke SK
    Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics of monoamine oxidase inhibition by three 2-indolylmethylamine derivatives.
    Cruces MA; Elorriaga C; Fernández-Alvarez E
    Biochem Pharmacol; 1990 Aug; 40(3):535-43. PubMed ID: 2383286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors.
    Horita A
    Int J Neuropharmacol; 1965 Nov; 4(6):337-42. PubMed ID: 4379937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.